22:
174:. The two men, with Isolina Mesquita who was plant manager for Bayer's Coimbra site, decided they would set up a new company, Bluepharma, with the aim of acquiring the Bayer plant and developing it as an integrated contract manufacturing business. The new company took the responsibility for all former Bayer employees, so the German work culture is still present in Bluepharma.
119:
294:
177:
Its buildings occupy about 14,000 square meters at several levels on a land area of 18,700 square meters. The buildings have had several improvements, the most significant being in 1989, when the site was still owned by Bayer, and in 1998. During the first half of the 2000s, the company built a
211:
Bluepharma has clients in
Portugal, France, Germany and in the UK, among others. One of Bluepharma's main clients is Bayer, to which the Portuguese company produced around 3.5 million units in 2004. Other clients include pharmaceuticals brands and companies such as Teva, Ivax, Arrow, EG LABO
165:. Bayer announced plans to sell the Coimbra manufacturing site by advertising in an international magazine. Paulo Barradas Rebelo, who had gained management and business skills and experience in logistics from a background as
169:
of a major wholesaler and distribution company to about 500 pharmacy units within a co-operative, read about the planned sale. He contacted Sérgio Simões, who worked in research locally as a professor at the
145:. Bluepharma became FDA approved since 2009 for the development of solid pharmaceutical forms, "becoming the first Portuguese pharmaceutical company to export to the US market."
362:
343:
372:
105:
377:
336:
43:
86:
58:
39:
367:
65:
329:
231:
Most
Bluepharma's employees have academic degrees, and many have post-graduate degrees (M.Sc. and PhDs) as well.
166:
72:
32:
130:
171:
54:
161:
multinational company made a business decision to consolidate production at its headquarters in
193:
309:
264:
79:
313:
305:
356:
244:
225:
178:
laboratory between the two main buildings to do more research and development work.
204:
21:
221:
118:
154:
142:
134:
301:
162:
158:
138:
240:
198:
293:
217:
213:
117:
15:
186:
Bluepharma develops its activity on the following areas:
129:(full name Bluepharma — Indústria Farmacêutica, SA) is a
317:
46:. Unsourced material may be challenged and removed.
153:Bluepharma's production plant was acquired from
243:area, Bluepharma has research projects in the
337:
8:
344:
330:
106:Learn how and when to remove this message
256:
7:
363:Pharmaceutical companies of Portugal
290:
288:
44:adding citations to reliable sources
157:when, at the end of the 1990s, the
14:
247:field and is developing generic.
292:
20:
137:ownership, which is located in
31:needs additional citations for
373:Organisations based in Coimbra
1:
316:. You can help Knowledge by
312:corporation or company is a
394:
287:
235:Research & Development
167:chief executive officer
190:Contract-manufacturing
131:pharmaceutical company
123:
378:Medical company stubs
300:This article about a
172:University of Coimbra
121:
40:improve this article
269:www.cphi-online.com
265:"About Bluepharma"
194:Biopharmaceuticals
124:
368:Portuguese brands
325:
324:
116:
115:
108:
90:
385:
346:
339:
332:
310:biotechnological
296:
289:
279:
278:
276:
275:
261:
111:
104:
100:
97:
91:
89:
48:
24:
16:
393:
392:
388:
387:
386:
384:
383:
382:
353:
352:
351:
350:
285:
283:
282:
273:
271:
263:
262:
258:
253:
237:
184:
151:
122:Bluepharma logo
112:
101:
95:
92:
49:
47:
37:
25:
12:
11:
5:
391:
389:
381:
380:
375:
370:
365:
355:
354:
349:
348:
341:
334:
326:
323:
322:
306:pharmaceutical
297:
281:
280:
255:
254:
252:
249:
236:
233:
224:) and Ciclum (
209:
208:
201:
196:
191:
183:
180:
150:
147:
114:
113:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
390:
379:
376:
374:
371:
369:
366:
364:
361:
360:
358:
347:
342:
340:
335:
333:
328:
327:
321:
319:
315:
311:
307:
303:
298:
295:
291:
286:
270:
266:
260:
257:
250:
248:
246:
245:biotechnology
242:
234:
232:
229:
227:
223:
219:
215:
206:
202:
200:
197:
195:
192:
189:
188:
187:
181:
179:
175:
173:
168:
164:
160:
156:
148:
146:
144:
140:
136:
132:
128:
120:
110:
107:
99:
88:
85:
81:
78:
74:
71:
67:
64:
60:
57: –
56:
52:
51:Find sources:
45:
41:
35:
34:
29:This article
27:
23:
18:
17:
318:expanding it
299:
284:
272:. Retrieved
268:
259:
238:
230:
210:
203:Commerce of
185:
176:
152:
126:
125:
102:
93:
83:
76:
69:
62:
55:"Bluepharma"
50:
38:Please help
33:verification
30:
207:in Portugal
357:Categories
274:2020-04-08
251:References
226:Grünenthal
222:Ratiopharm
220:), Mepha (
216:), Bexal (
135:Portuguese
127:Bluepharma
66:newspapers
96:June 2007
205:generics
182:Business
155:Bayer AG
143:Portugal
302:medical
241:R&D
239:In the
199:R&D
163:Germany
149:History
139:Coimbra
80:scholar
159:German
82:
75:
68:
61:
53:
218:Hexal
214:Stada
87:JSTOR
73:books
314:stub
59:news
308:or
228:).
133:of
42:by
359::
304:,
267:.
141:,
345:e
338:t
331:v
320:.
277:.
212:(
109:)
103:(
98:)
94:(
84:·
77:·
70:·
63:·
36:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
